Arcutis Biotherapeutics, Inc. (ARQT) scores 37 out of 100 on boothcheck's 11-model valuation framework. Verdict: Strong Avoid The estimated fair value is $13.68, representing a 39% premium to fair value. Quantitative score: 45/100. Qualitative score: 50/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.